---
title: "ZBD: The application for the listing of hydrochloride paroxetine chemical raw materials has been approved"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/228170118.md"
description: "According to the Zhontong Finance APP, ZBD announced that its Jixi branch has received the \"Approval Notice for the Application for the Listing of Chemical Raw Materials\" issued by the National Medical Products Administration. The name of the chemical raw material is Paroxetine Hydrochloride, which is used to treat various types of depression, including depression accompanied by anxiety and reactive depression"
datetime: "2025-02-13T09:42:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/228170118.md)
  - [en](https://longbridge.com/en/news/228170118.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/228170118.md)
generator: "portal-rs"
---

# ZBD: The application for the listing of hydrochloride paroxetine chemical raw materials has been approved

According to the Zhontong Finance APP, ZBD (603567.SH) announced that its Jixi branch received the "Approval Notice for the Application for the Listing of Chemical Raw Materials" issued by the National Medical Products Administration. The name of the chemical raw material is Paroxetine Hydrochloride, which is used to treat various types of depression, including depression accompanied by anxiety and reactive depression

### Related Stocks

- [603567.CN](https://longbridge.com/en/quote/603567.CN.md)

## Related News & Research

- [Mowi Stock And European Seafood Shares Worth A Closer Look](https://longbridge.com/en/news/297288331.md)
- [Signs of Weak European Sugar Production Support Prices](https://longbridge.com/en/news/297077989.md)
- [Iceland votes on whether to start EU membership talks](https://longbridge.com/en/news/297397685.md)
- [Iceland votes on whether to start EU membership talks](https://longbridge.com/en/news/297377123.md)
- [Collins urges US to return to trade talks with Canada](https://longbridge.com/en/news/297223742.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**